Cell cycle dependent induction of apoptosis by somatostatin analog SMS 201-995 in AtT-20 mouse pituitary cells.
Somatostatin (SS) and its analogs exert direct antiproliferative effects in a variety of tumor cells not only by inhibiting the mitogenic signalling of growth factor receptor kinases, but also by inducing apoptosis. In this study, the apoptotic effect of the octreotide SS analog, SMS 201-995, was investigated in phase synchronized AtT-20 mouse pituitary tumor cells. SMS 201-995 added to cells synchronized in G1 or in G2 phases induces apoptosis which is manifested in the subsequent cell cycle. No evidence of apoptosis was seen in cells subjected to cell cycle arrest in G1 by lovastatin or in G2 with 160 nM staurosporine. SMS 201-995 did not induce detectable apoptosis in unsynchronized cells which remained predominantly in G1 phase. These findings provide the first documentation that SS peptides regulate cell growth in G2 to induce apoptosis.
Srikant
C B
CB
Fraser Laboratories for Diabetes Research, Department of Medicine, McGill University, Montreal, Quebec, Canada.
D000818:Animals; D017209:Apoptosis / Q000187:drug effects*; D002453:Cell Cycle / Q000187:drug effects*; D004305:Dose-Response Relationship, Drug; D005434:Flow Cytometry; D066298:In Vitro Techniques; D051379:Mice; D015282:Octreotide / Q000494:pharmacology*; D010911:Pituitary Neoplasms / Q000473:pathology*; D014407:Tumor Cells, Cultured
D015282:Octreotide